Obesity: Appetite drug could mark 'new era' in tackling condition

Obesity: Appetite drug could mark 'new era' in tackling condition A drug that suppresses appetite has led to some people losing more than a fifth of their body weight, a major international trial shows.

A weekly injection of the drug, semaglutide, was given alongside advice on diet and fitness.

The study, conducted on almost 2,000 people, showed an average 15kg weight loss during the 15-month trial. BBC News

See also:

• Once-Weekly Semaglutide in Adults with Overweight or Obesity (abstract) New England Journal of Medicine